Share of resistant S. pneumoniae in EU/EEA by antimicrobial group

Streptococcus pneumoniae is a bacteria causing a wide range of infections, from otitis to pneumonia and meningitis, with high mortality in vulnerable patient groups. As of 2021, resistance to macrolide antibiotics was the most common form of S. pneumoniae antibiotic resistance in EU and EEA countries, with 18.3 percent, followed by resistance to penicillin non-wild-type. This statistic displays the percentage of invasive Streptococcus pneumoniae isolates resistant to antibiotics in EU/EEA countries between 2017 and 2021, by antimicrobial group.

Percentage of invasive Streptococcus pneumoniae isolates resistant to antibiotics in EU/EEA countries between 2017 and 2021, by antimicrobial group

Characteristic	Penicillin non-wild-type	Macrolide (azithromycin/clarithromycin/erythromycin) resistance	Combined penicillin non-wild-type and resistance to macrolides
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

April 2023

More information

Region

Worldwide, Europe

Survey time period

2017 to 2021

Supplementary notes

Streptococcus pneumoniae is a bacteria causing a wide range of infections, from otitis to pneumonia and meningitis, with high mortality in vulnerable patient groups.
All EU Member States and two EEA countries (Island and Norway) reported data from invasive isolates, except for UK in 2020 and 2021. Roughly 76 percent of the participating countries had a high national representativeness, in terms of covered geographic areas, included acute care hospitals, and microorganisms causing infections.

Citation formats